TA Treatment of Depression: A Hermeneutic Single-Case Efficacy Design Study - ‘Anna’

Abstract

This study is the first of a series of seven, and belongs to the second Italian systematic replication of findings from two previous series (Widdowson 2012a(Widdowson , 2012b(Widdowson , 2012c(Widdowson , 2013Benelli, 2016aBenelli, , 2016bBenelli, , 2016c) that investigated the effectiveness of a manualised transactional analysis treatment for depression through Hermeneutic SingleCase Efficacy Design (HSCED). The therapist was a white Italian woman with 8 years of clinical experience and the client, Anna, was a 33-year old white Italian woman who attended 16 sessions of transactional analysis psychotherapy. Anna satisfied DSM-5 criteria for mild persistent depressive disorder (dysthymia) with anxious distress. The conclusion of the judges was that this was a good-outcome case: the dysthymic symptoms improved over the course of the therapy and were maintained in the 'healthy' range at the 6-month followup, the client reported a positive experience of the therapy and described important changes in intrapsychic and interpersonal patterns. In this case study, transactional analysis treatment for depression has proven its efficacy in treating persistent depressive disorder.

Treatment of obsessive morbid jealousy with cognitive analytic therapy: An adjudicated hermeneutic single‐case efficacy design evaluation

“…A recent example an adjudicated HSCED is Benelli et al . 's () evaluation of the transactional analysis treatment of depression.…”

TA Treatment of Depression: A Simplified Hermeneutic Single-Case Efficacy Design - The Case of “Margherita”

“…Recently, since the publication of the first Hermeneutic Single-Case Efficacy Design (HSCED) applied to transactional analysis (TA) treatment of depression (Widdowson, 2012a) there have been one direct replication of three single cases (Widdowson, 2012b(Widdowson, , 2012c(Widdowson, , 2013 and three Italian systematic replications of three single cases each (Benelli, Revello, Piccirillo, Mazzetti, Calvo, Palmieri, Sambin & Widdowson, 2016a;Benelli, Scottà, Barreca, Palmieri, Calvo, De Renoche, Colussi, Sambin, & Widdowson, 2016b;Benelli, Boschetti, Piccirillo, Quagliotti, Calvo, Palmieri, Sambin, & Widdowson, 2016c;Benelli, Moretti, Cavallero, Greco, Calvo, Mannarini, Palmieri & Widdowson, 2017a;Benelli, Filanti, Musso, Calvo, Mannarini, Palmieri & Widdowson, 2017b;Benelli, Bergamaschi, Capoferri, Morena, Calvo, Mannarini, Palmieri, Zanchetta & Widdowson, 2017c;Benelli, Procacci, Fornaro, Calvo, Mannarini, Palmieri & Zanchetta, 2018a;Benelli, Gentilesca, Boschetti, Piccirillo, Calvo, Mannarini, Palmieri & Zanchetta, 2018b;Benelli, Vulpiani, Cavallero, Calvo, Mannarini, Palmieri & Zanchetta, 2018c) aiming to recognise TA psychotherapy for depression as an Empirically Supported Treatment. Moreover, with the HSCED methodology Kerr (2013) evaluated TA treatment for emetophobia.…”

TA Treatment of Depression: A Hermeneutic Single-Case Efficacy Design Study - 'Giorgio'

“…This Hermeneutic Single-Case Efficacy Design (HSCED) is the fourth of a series of seven, and belongs to an Italian systematic replication of findings from previous case series (Widdowson 2012a(Widdowson , 2012b(Widdowson , 2012c(Widdowson , 2013(Widdowson , 2014Benelli, 2016aBenelli, , 2016bBenelli, , 2016cBenelli, , 2017aBenelli, , 2017bBenelli, , 2017c and is conducted under the auspices of the project 'Transactional Analysis meets Academic Research in order to become an Empirically Supported Treatment: an Italian two-year plan for publishing evidence of Transactional Analysis efficacy and effectiveness into worldwide recognized scientific journals', funded by the European Association for Transactional Analysis (EATA). Previous publications have widely described the rationale for supporting by HSCED the accumulation of evidences of efficacy and effectiveness for those models of psychotherapy that are emerging or marginalized (Benelli, De Carlo, Biffi & McLeod, 2015) and specifically how this is important for recognition of TA and inclusion within the acknowledged treatments for common mental disorders (i.e., depression, anxiety and personality disorders) (Widdowson 2012a(Widdowson , 2012b(Widdowson , 2012c(Widdowson , 2013(Widdowson , 2014Benelli, 2016aBenelli, , 2016bBenelli, , 2016cBenelli, , 2017aBenelli, , 2017bBenelli, , 2017c.…”